US 11267893
Anti-IL36R antibodies
granted A61KA61K2039/505A61K45/06
Quick answer
US patent 11267893 (Anti-IL36R antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K45/06, A61K9/0019, A61P